Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age
Sponsor: University of Oulu
Summary
The aim of the trial is to evaluate whether the use of oral prednisolone directed by point-of-care testing is useful in acute wheezing caused by rhinovirus in children aged 6-24 months.
Official title: Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age: a Point-of-care Testing Guided Randomized, Double-blind, Placebo-controlled Trial
Key Details
Gender
All
Age Range
6 Months - 24 Months
Study Type
INTERVENTIONAL
Enrollment
210
Start Date
2022-10-11
Completion Date
2027-09
Last Updated
2025-02-13
Healthy Volunteers
No
Conditions
Interventions
Prednisolone Sodium Phosphate
Oral suspension administered 1 mg/kg once a day for three days
Sugar syrup
Oral suspension administered the same amount in milliliters as experimental product once a day for three days
Locations (2)
SOITE Lastenpäivystys
Kokkola, Finland
OYS Lastenpäivystys
Oulu, Finland